SFU
EPZM

Stonehage Fleming (UK)’s Epizyme, Inc EPZM Stock Holding History

Stonehage Fleming (UK)’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-488
Closed -$13K – 344
2014
Q3 		$13K Sell
488
-232
-32% -$7.21K 0.01% 286
2014
Q2 		$22K Sell
720
-779
-52% -$18.3K 0.01% 233
2014
Q1 		$34K Hold
1,499
– – 0.01% 278
2013
Q4 		$31K Buy
+1,499
New +$43.5K 0.01% 252

Other funds holding EPZM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Stonehage Fleming (UK)'s EPZM Position: Q4 2014 in Review

Stonehage Fleming (UK) sold out of Epizyme, Inc (EPZM) in Q4 2014, closing a stake of 488 shares — an estimated $13K sold.

Stonehage Fleming (UK) first reported a position in EPZM in Q4 2013 and held it in 4 quarters. The position peaked at $34K in Q1 2014. 82 funds tracked by Wall St. Rank hold EPZM as of Q4 2014.

  • Stonehage Fleming (UK) reported no remaining Epizyme, Inc position as of Q4 2014 after selling out during the quarter.
  • Stonehage Fleming (UK) sold 488 Epizyme, Inc shares in Q4 2014, an estimated $13K.
  • Stonehage Fleming (UK) first reported a position in Epizyme, Inc in Q4 2013 and held it in 4 quarters.
  • Stonehage Fleming (UK)'s Epizyme, Inc position peaked at $34K in Q1 2014.
  • 82 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2014.

Based on Stonehage Fleming (UK)'s 13F filing for Q4 2014, filed 11 Oct 2019.